Ambulatory Care Pharmacy Core Therapeutic Module Package for Recertification (Cert # L189187)

ACPE Numbers: Various – see listing below
Release Date: 11/14/2018
Expiration Date: 05/14/2019
Activity Type: Application-based
CE Credits: 3.5 hours (Recertification and ACPE)
Activity Fee: $100 (ASHP member); $150 (non-member) 

APhA Members:
To receive the member rate when purchasing this activity, enter “APhA18CTM2” in the promotion code field at check out.
 

Accreditation for Pharmacists

ASHP and APhA are accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education.

Target Audience

These activities are intended for Board Certified Ambulatory Care Specialists in need of recertification credit.

Activity Overview

The Core Therapeutic Modules for Recertification Package consists of 3 activities (see table below). In each activity, faculty review clinical topics and practice skills using a case-based approach. This package is intended for board certified pharmacists in need of recertification credit; the activities were designed based on the content outline developed by the Board of Pharmacy Specialties (BPS).

Successful completion of all the learning modules will provide up to 3.5 hours of continuing pharmacy education credit.

Recertification Credit

Board certified pharmacists are eligible to receive 3.5 hours of recertification credit for completing this module. To earn recertification credit, learners must review the activity content and successfully complete the online assessment by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Participants who pass the assessments will be eligible for recertification credit in the year in which the assessment was completed.

These activities are part of the professional development programs for BCACP recertification approved by the BPS. 

ACPE Number

Learning Module

Credit Hours

Pass Point

0204-0000-18-603-H01-P

Select Topics in Psychiatric Disorders*

1



75%

0204-0000-18-604-H01-P

Select Topics in Rheumatology*

1

0204-9999-18-999-H03-P

Pharmacotherapy Considerations in the Management of HIV and AIDS**

1.5

 

Learning Objectives

Select Topics in Psychiatric Disorders
0204-0000-18-603-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • For patients with bipolar disorder, schizophrenia, anxiety disorder, and post-traumatic stress disorder
    • Identify basic diagnostic factors, clinical presentation, and target symptoms of selected psychiatric disorders.
    • Determine the most appropriate treatment and monitoring based on patient-specific information and the most current guidelines.
    • Assess available information to identify drug-related problems and response to therapy.
    • Recommend appropriate modifications of patient-specific treatment plans based on follow up assessment. 

Selected Topics in Rheumatology
0204-0000-18-604-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • For patients with rheumatoid arthritis, osteoarthritis, gout
    • Determine the most appropriate treatment based on patient-specific information and the most current literature.
    • Assess available information to identify drug-related problems and response to therapy.
    • Identify appropriate modifications of patient-specific treatment plans based on follow-up assessment. 

Pharmacotherapy Considerations in the Management of HIV and AIDS
0204-9999-18-999-H03-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • For patients with HIV infection:
    • Determine the most appropriate guideline-directed therapy based on patient-specific information.
    • Manage and prevent opportunistic infections.
    • Explain recommendations for preventing transmission of HIV infection.
    • Demonstrate a knowledge of occupational post-exposure antiretroviral therapy guidelines.
    • Resolve HIV drug-related problems including drug interactions.
    • Evaluate therapeutic and monitoring plans for patients receiving antiretroviral therapy. 

Faculty

Jessica Farrell, Pharm.D.
Associate Professor
Albany College of Pharmacy and Health Sciences
Clinical Pharmacist
The Center for Rheumatology
Albany, NY 

Suzanne Harris, Pharm.D., BCPP, CPP
Clinical Assistant Professor
UNC Eshelman School of Pharmacy
Clinical Pharmacist Practitioner
UNC Medical Center
Chapel Hill, NC 

Douglas Slain, Pharm.D., BCPS, FASHP
Professor & Infectious Diseases Clinical Specialist
West Virginia University
Morgantown, WV 

Content Matter Experts

Christopher Betz, Pharm.D., BCPS, FKSHP, FASHP
Associate Professor, Clinical and Administrative Sciences
Sullivan University College of Pharmacy
Louisville, Kentucky 

Snehal H. Bhatt, Pharm.D., BCPS
Associate Professor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Sciences
Boston, Massachusetts 

Kelly T. Epplen, Pharm.D., BCACP, FASHP
Associate Professor of Clinical Pharmacy
James L. Winkle College of Pharmacy, University of Cincinnati
Edgewood, Kentucky 

Stuart T. Haines, Pharm.D., BCPS, BCACP, BC-ADM
Professor and Director, Pharmacy Professional Development
University of Mississippi School of Pharmacy
Jackson, Mississippi 

Joel C. Marrs, Pharm.D., BCACP, BCPS-AQ-Cardiology, CLS, ASH-CHC
Associate Professor
University of Colorado Skaggs School of Pharmacy & Pharmaceutical Sciences
Aurora, Colorado 

Douglas Slain, Pharm.D., BCPS (AQ-ID), FCCP, FASHP
Associate Professor and Infectious Diseases Clinical Specialist
West Virginia University School of Pharmacy
Morgantown, West Virginia 

Reviewers

Susan R. Dombrowski, M.S., R.Ph.
Kristi Hofer, Pharm.D.
Anna Jackson, Pharm.D., BCPS 

Field Testers

Jeremy Anderson, Pharm.D., BCACP
Shaneka Baylor, Pharm.D., BCGP, BCACP
Marguerite Conger, Pharm.D., BCACP
Lisa Dykes, Pharm.D., BCACP, BCPS, MHA
Rhianna Fink, Pharm.D., BCACP
Amparo Gonzalez ODell, Pharm.D.,BCPS
Alvin Goo, Pharm.D., BCACP
MaRanda Herring, Pharm.D., BCACP
Rachael Hiday, Pharm.D., BCPS, BCACP, MBA
Cassandra Hobbs, Pharm.D., BCACP, LDE, MBA
Jonathan Hoffman, Pharm.D., BCACP
Alexis Horace, Pharm.D., BCACP
Juliann Horne, Pharm.D., BCACP
Tiffany Jenkins, Pharm.D., BCACP
Jessica Johnson, Pharm.D., BCACP
Jillian Koczela, Pharm.D., BCACP
Paul Le, Pharm.D., BCACP, BCGP, BCPS
Brian Leonard, Pharm.D., BCACP
Matthew Maddox, Pharm.D., BCACP, BCGP
Alexandra Polito, Pharm.D., BCACP
Claire Rodrigues, Pharm.D., BCACP
Susan Rowe, Pharm.D., BCACP
Katherine Sauer, Pharm.D., BCACP
Nicholas Sciacca, Pharm.D., BCACP
S. Rochelle Sullivan, Pharm.D., BCACP
Patty Taddei-Allen, Pharm.D., MBA, BCACP, BCGP
David Tsung, Pharm.D., BCACP
Chinyelu Umeano, Pharm.D., BCACP
Jason Wachtl, Pharm.D., BCACP, BCGP
Jessica Yoo, Pharm.D., BCACP 

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identify and resolve conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity. 

  •          All planners, presenters, and reviewers of this course report no financial relationships relevant to this activity.

Methods and CE Requirements

This Core Therapeutic Module Recertification Package consists of 3 activities which can be completed in any order. Each activity consists of audio and slides, an attestation statement, and an activity evaluation. Learners must review all content and complete the attestation statement and evaluation to receive continuing pharmacy education credit for each activity.

Follow the prompts to claim, view, or print the statement of credit immediately after completing the activities.

System Technical Requirements

Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.

View the minimum technical and system requirements for learning activities.

Development

* Developed by ASHP 
** Developed by ASHP and APhA

To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for Board Certification Examinations.